Foluso N Ogunleye MD

Physician

18000 Studebaker RdSte 800Cerritos, CA 90703
Phone+1 562-735-3226
Fax+1 480-882-5018

Dr. Ogunleye is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ogunleye's full profile Already have an account?

Summary

Dr. Foluso Ogunleye is an oncologist at The Oncology Institute, Vista and Temecula offices, CA. He is affiliated with multiple hospitals in the area, including Scripps Mercy hospital San Diego, Scripps Hospital Encinitas, Loma Linda Hospital, Murrieta, The Valley Hospital, Temecula, Rancho Spring Hospital, Murrieta, Inland Valley Hospital, Mennefi, and Sharp memorial Hospital, Chula Vista. He received his medical degree from University of Benin Faculty of Medicine and has been in practice 16 years. He specializes in hematologic oncology and is experienced in gastrointestinal malignancy, genitourinary cancer, neuro-oncology, amyloidosis, hematologic oncology, breast cancer, and prostate cancer.

Education & Training

Corewell Health William Beaumont University HospitalFellowship, Hematology and Medical Oncology, 2014 - 2017
Roger Williams Medical CenterResidency, Internal Medicine, 2005 - 2008
University of Benin Faculty of MedicineClass of 2001

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

AZ State Medical License 2017 - 2027
NV State Medical License 2019 - 2027
CA State Medical License 2018 - 2026
MI State Medical License 2014 - 2018
GA State Medical License 2011 - 2016
IL State Medical License 2006 - 2014
IA State Medical License 2008 - 2013
RI State Medical License 2005 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Join now to see all

Publications & Presentations

PubMed

68 citations
Male BRCA mutation carriers: clinical characteristics and cancer spectrum.
Mohammed Ibrahim, Siddhartha Yadav, Foluso Ogunleye, Dana Zakalik
BMC Cancer. 2018-02-13
Unusual Presentation of a Small-Cell Variant of Anaplastic Large-Cell Lymphoma Case: When a Septic Picture Is Not Sepsis
Zhou Yu, Yifan Pang, Linda Wang, Daniel Ezekwudo, Foluso Ogunleye
Case Reports in Hematology. 2017-09-24
Reply to S.E. Langabeer.
Foluso Ogunleye, James Huang, Mohammed Ibrahim, Emily Allen, Neil Brennan
Journal of Oncology Practice. 2017-02-14

Journal Articles

Ibrutinib as a Bruton's Tyrosine Kinase Inhibitor in the management of Chronic Lymphocytic Lymphoma
Ogunleye Foluso, MD Alexander Glick, MD Michael Stender, MD Ishmael Jaiyesimi, DO, Clinical lymphoma Myeloma and Leukemia
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advance Non-Small Cell Lung Cancer. A paradigm shift in Stage IV NSCLC treatment
Foluso Ogunleye, MD Mohammed Ibrahim, MD Michael Stender, MD Gregory Kalemkeriam, MD Ishmael Jaiyesimi DO, American Journal of Hematology/Oncology, 1/16/2015

Abstracts/Posters

Programmed cell death-1/Programmed cell death ligand-1(PD-1/PD-L1) inhibitors, heralding a new era of immunotherapy in the management of advanced Non-Small Cell Lung C...
Foluso Ogunleye, LeAnn Blankenship, Vanessa Millisor, Joseph Anderson, Ishmael Jaiyesimi, ancer Treatment and Research Communications, Volume 12, 2017, Pages 6-13, ISSN 2468-2942, https://doi.org/10.1016/j.ctarc.2017.05.002., 5/2/2017
Treatment patterns for resected gastric cancer using the National Cancer Database.
Foluso Nelson Ogunleye, Karna Tushar Sura, Leann Blankenship, Daniel Ezekwudo, Bolanle Gbadamosi, Ishmael A. Jaiyesimi, and Peyman Kabolizadeh, Journal of Clinical Oncology 2017 35:15_suppl, 4061-4061, 5/1/2017